Relmada Therapeutics, Inc. (RLMD)

NASDAQ

$3.38

$-0.14

(-3.99%)

Pre-Market

Relmada Therapeutics, Inc. (RLMD) Live Price Chart

Last updated: ⁦2026-10-14 12:37:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Relmada Therapeutics, Inc. (RLMD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.38, with a market capitalisation of $374.41M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.80 to $8.00. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$374.41M
Open	$3.50
Day's High	$54.00
Day's Low	$0.24
Previous Close	$3.51
Volume	1.31M
Average Volume	1.34M
P/E Ratio	--
52-Week High	$8.00
52-Week Low	$1.80
Dividend Yield	--
Earnings Date	--

Relmada Therapeutics, Inc. (RLMD) Pre-Market Stock Price

Relmada Therapeutics, Inc. (RLMD) is trading at $3.42 in pre-market trading as of 2026-10-13 23:47:00, down 2.56% ($0.09) from the previous close of $3.51

Pre-market trading shows how investors are pricing RLMD before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Relmada Therapeutics, Inc. (RLMD) 7-Day Stock Price Change

Over the past seven days, Relmada Therapeutics, Inc. (RLMD) moved from $3.48 to $3.38, representing a decline of 3.02% ($0.10).

The stock traded between $3.10 and $3.70 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 1.57 million shares, up versus the previous seven-day period, indicating higher trading activity.

RLMD 52-Week Price Position

Position in Range: 25.4%

52W Low$1.80

52W High$8.00

RLMD is currently trading at $3.38, placing it 25.4% of the way from its 52-week low of $1.80 to its 52-week high of $8.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Relmada Therapeutics, Inc. (RLMD)?

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Relmada Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	17
Exchange	NASDAQ
Company Website	https://www.relmada.com

How to Buy Relmada Therapeutics, Inc. (RLMD) Stock on MEXC

Eligible investors can buy real shares of Relmada Therapeutics, Inc. (RLMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for RLMD and Place Your Order

Open the RealStocks trading page and search for RLMD. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Relmada Therapeutics, Inc. (RLMD) stock price today?

Relmada Therapeutics, Inc. (RLMD) is currently trading at $ 3.38, down 3.85% ($0.13) from the previous close of $ 3.51. Intraday prices update in real time during regular trading hours.

2.Is RLMD stock going up or down today?

As of 2026-10-13 23:47:00, RLMD is trading at $ 3.38, down 3.85% ($0.13) from its previous close of $ 3.51. The stock has traded between $ 0.24 and $ 54.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is RLMD pre-market price?

As of 2026-10-13 23:47:00, RLMD is trading at $ 3.42 in pre-market trading, down 2.56% ($0.09) from the previous close of $ 3.51. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is RLMD after-hours price?

As of 2026-10-13 23:47:00, RLMD is trading at $ 3.38 in after-hours trading, down 3.85% ($0.13) from the regular-session close of $ 3.51. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is RLMD stock trading now?

RLMD trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does RLMD sit relative to its 52-week high and low?

Over the past 52 weeks, RLMD has traded between a low of $ 1.80 and a high of $ 8.00. At $ 3.38, the stock is positioned 25.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Relmada Therapeutics, Inc. in?

Relmada Therapeutics, Inc. (RLMD) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Relmada Therapeutics, Inc.'s market capitalisation and where is it listed?

Relmada Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 374.41M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is RLMD valued in terms of P/E ratio and EPS?

RLMD trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.58. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Relmada Therapeutics, Inc. pay a dividend?

Relmada Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.